ng table provides a reconciliation of net income and EBITDASO
for the three-month periods ended December 31, 2007 and 2006, and for the
years ended December 31, 2004 through 2007 (in thousands, except per share
data):
Year ended December 31,
2004 2005 2006 2007
Net income, as reported $15,449 $65,016 $73,965 $19,859
Add (subtract) back:
Interest expense 4 29 482 2,175
Income tax (benefit) - (17,494) (34,057) (3,276)
One time expense - - 2,024 14,595
Depreciation and
amortization 2,381 2,534 2,713 3,427
Stock option expense 329 983 23,513 48,766
EBITDASO $18,163 $51,068 $68,640 $85,546
EBITDASO earnings per
share (1):
Basic $0.84 $2.24 $2.98 $4.03
Diluted $0.78 $2.03 $2.84 $3.81
Three months ended
December 31,
2007 2006
Net income, as reported $1,986 $55,508
Add (subtract) back:
Interest expense 34 481
Income tax (benefit) (7,104) (47,718)
One time expense 2,067 -
Depreciation and
amortization 941 770
Stock option expense 26,792 9,687
EBITDASO $24,716 $18,728
EBITDASO earnings per
share (1):
Basic $1.14 $0.86
Diluted $1.04
'/>"/>
SOURCE United Therapeutics Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 Related biology technology :1.
United States Patent Office Grants CryoCors Request for Patent Interference2.
United Therapeutics to Announce Fourth Quarter and Annual 2007 Financial Results Before Market Open on Tuesday, February 19, 20083.
Energy Conversion Devices and United Solar Ovonic Enter Into New $55 Million Secured Credit Facility Agreements4.
Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor5.
Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement6.
Neptune Technologies receives GRAS notification in the United States7.
Essilor: New Acquisitions in the United States and Brazil8.
Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States9.
Medical Services Begins Working With United States Companies for Distribution of Its Products10.
United Therapeutics Reports Third Quarter 2007 Financial Results11.
Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States